Marksans Pharma Ltd.
•₹ 321.30.14%
2026-08-21
PROS
- Company has delivered good profit growth of 25.0% CAGR over last 5 years
- Company is almost debt free
- Latest quarter profit grew 43.6% YoY, showing strong momentum
- Company has delivered good sales growth of 17.5% CAGR over last 5 years
- Stock looks reasonably valued - P/E of 23.7 is below its historical median
- Company generates healthy free cash flow
CONS
- A large part of profit comes from other income (26.4% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.44x)
- Though reporting repeated profits, the company pays out little dividend (13.6%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | MARKSANS | 320.60 | 28.12 | 14528.43 | 0.28 | 159.41 | 173.89 | 840.80 | 35.61 | 21.10 | 25.34 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 182 | 205 | 241 | 225 | 255 | 309 | 312 | 299 | 320 | 320 | 340 | 362 | 321 | |
| 155 | 167 | 199 | 191 | 213 | 245 | 260 | 248 | 250 | 248 | 264 | 256 | 248 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 33 | 16 | 1 | 12 | 8 | 20 | 31 | 7 | 2 | 58 | 16 | 27 | 17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 9 |
| 54 | 44 | 35 | 38 | 42 | 76 | 75 | 50 | 64 | 121 | 82 | 124 | 90 | |
| Tax % | 18.75% | 29.69% | 26.91% | 14.09% | 24.30% | 17.20% | 25.78% | 24.67% | 24.41% | 17.85% | 25.82% | 26.09% | 23.68% |
| Net Profit | 44 | 31 | 25 | 33 | 32 | 63 | 55 | 38 | 48 | 100 | 61 | 92 | 69 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 182
- 155
- Operating Profit
- —
- OPM %
- —
- Other Income
- 33
- Interest
- 0
- Depreciation
- 5
- 54
- Tax %
- 18.75%
- Net Profit
- 44
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 205
- 167
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 0
- Depreciation
- 8
- 44
- Tax %
- 29.69%
- Net Profit
- 31
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 241
- 199
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 8
- 35
- Tax %
- 26.91%
- Net Profit
- 25
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 225
- 191
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 0
- Depreciation
- 7
- 38
- Tax %
- 14.09%
- Net Profit
- 33
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 255
- 213
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 7
- 42
- Tax %
- 24.30%
- Net Profit
- 32
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 309
- 245
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 0
- Depreciation
- 7
- 76
- Tax %
- 17.20%
- Net Profit
- 63
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 312
- 260
- Operating Profit
- —
- OPM %
- —
- Other Income
- 31
- Interest
- 0
- Depreciation
- 7
- 75
- Tax %
- 25.78%
- Net Profit
- 55
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 299
- 248
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 0
- Depreciation
- 8
- 50
- Tax %
- 24.67%
- Net Profit
- 38
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 320
- 250
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 8
- 64
- Tax %
- 24.41%
- Net Profit
- 48
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 320
- 248
- Operating Profit
- —
- OPM %
- —
- Other Income
- 58
- Interest
- 0
- Depreciation
- 8
- 121
- Tax %
- 17.85%
- Net Profit
- 100
- 2
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 340
- 264
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 0
- Depreciation
- 9
- 82
- Tax %
- 25.82%
- Net Profit
- 61
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 362
- 256
- Operating Profit
- —
- OPM %
- —
- Other Income
- 27
- Interest
- 0
- Depreciation
- 9
- 124
- Tax %
- 26.09%
- Net Profit
- 92
- 2
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 321
- 248
- Operating Profit
- —
- OPM %
- —
- Other Income
- 17
- Interest
- 0
- Depreciation
- 9
- 90
- Tax %
- 23.68%
- Net Profit
- 69
- 0
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 216 | 295 | 424 | 433 | 600 | 658 | 655 | 853 | 1,174 | 1,341 | 1,343 | |
| 202 | 266 | 361 | 362 | 486 | 545 | 582 | 713 | 966 | 1,018 | 1,016 | |
| Operating Profit | 31 | 37 | 71 | 72 | 145 | 156 | 152 | 202 | 274 | 427 | — |
| OPM % | 15 | 12 | 17 | 17 | 24 | 24 | 23 | 24 | 23 | 32 | — |
| Other Income | 18 | 7 | 8 | 0 | 31 | 42 | 79 | 62 | 66 | 104 | 119 |
| Interest | 4 | 8 | 7 | 7 | 5 | 4 | 4 | 1 | 1 | 1 | 1 |
| Depreciation | 15 | 12 | 9 | 12 | 15 | 18 | 17 | 29 | 29 | 34 | 35 |
| 12 | 17 | 56 | 53 | 124 | 135 | 132 | 172 | 243 | 392 | 418 | |
| Tax % | 3 | 25 | 22 | 28 | 21 | 23 | 22 | 22 | 23 | 23 | 23 |
| Net Profit | 12 | 12 | 44 | 38 | 98 | 104 | 103 | 134 | 188 | 301 | 322 |
| EPS | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | 7 | — |
| Dividend Payout % | 18 | 16 | 5 | 11 | 10 | 10 | 22 | 20 | 19 | 14 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | 7 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | 7 | — |
Mar 2017
- 216
- 202
- Operating Profit
- 31
- OPM %
- 15
- Other Income
- 18
- Interest
- 4
- Depreciation
- 15
- 12
- Tax %
- 3
- Net Profit
- 12
- EPS
- 0
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2018
- 295
- 266
- Operating Profit
- 37
- OPM %
- 12
- Other Income
- 7
- Interest
- 8
- Depreciation
- 12
- 17
- Tax %
- 25
- Net Profit
- 12
- EPS
- 0
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2019
- 424
- 361
- Operating Profit
- 71
- OPM %
- 17
- Other Income
- 8
- Interest
- 7
- Depreciation
- 9
- 56
- Tax %
- 22
- Net Profit
- 44
- EPS
- 1
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 433
- 362
- Operating Profit
- 72
- OPM %
- 17
- Other Income
- 0
- Interest
- 7
- Depreciation
- 12
- 53
- Tax %
- 28
- Net Profit
- 38
- EPS
- 1
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2021
- 600
- 486
- Operating Profit
- 145
- OPM %
- 24
- Other Income
- 31
- Interest
- 5
- Depreciation
- 15
- 124
- Tax %
- 21
- Net Profit
- 98
- EPS
- 2
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2022
- 658
- 545
- Operating Profit
- 156
- OPM %
- 24
- Other Income
- 42
- Interest
- 4
- Depreciation
- 18
- 135
- Tax %
- 23
- Net Profit
- 104
- EPS
- 3
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 655
- 582
- Operating Profit
- 152
- OPM %
- 23
- Other Income
- 79
- Interest
- 4
- Depreciation
- 17
- 132
- Tax %
- 22
- Net Profit
- 103
- EPS
- 2
- Dividend Payout %
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2024
- 853
- 713
- Operating Profit
- 202
- OPM %
- 24
- Other Income
- 62
- Interest
- 1
- Depreciation
- 29
- 172
- Tax %
- 22
- Net Profit
- 134
- EPS
- 3
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 1,174
- 966
- Operating Profit
- 274
- OPM %
- 23
- Other Income
- 66
- Interest
- 1
- Depreciation
- 29
- 243
- Tax %
- 23
- Net Profit
- 188
- EPS
- 4
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2026
- 1,341
- 1,018
- Operating Profit
- 427
- OPM %
- 32
- Other Income
- 104
- Interest
- 1
- Depreciation
- 34
- 392
- Tax %
- 23
- Net Profit
- 301
- EPS
- 7
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
TTM
- 1,343
- 1,016
- Operating Profit
- —
- OPM %
- —
- Other Income
- 119
- Interest
- 1
- Depreciation
- 35
- 418
- Tax %
- 23
- Net Profit
- 322
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 14%
- 5 Years:
- 17%
- 3 Years:
- 27%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 15%
- 5 Years:
- 25%
- 3 Years:
- 43%
STOCK PRICE CAGR
- 10 Years:
- 23%
- 5 Years:
- 36%
- 3 Years:
- 42%
- 1 Year:
- 77%
RETURN ON EQUITY
- 10 Years:
- 11%
- 5 Years:
- 15%
- 3 Years:
- 15%
- Last Year:
- 20%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 41 | 41 | 41 | 41 | 41 | 41 | 45 | 45 | 45 | 45 |
| 378 | 388 | 430 | 465 | 559 | 651 | 1,066 | 1,177 | 1,338 | 1,604 | |
| 73 | 66 | 77 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | |
| Trade Payables | 21 | 34 | 37 | 57 | 64 | 74 | 112 | 160 | 204 | 181 |
| 33 | 31 | 40 | 48 | 97 | 218 | 146 | 166 | 209 | 226 | |
| Total Liabilities | 546 | 560 | 625 | 610 | 761 | 989 | 1,369 | 1,548 | 1,796 | 2,056 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 94 | 88 | 103 | 115 | 129 | 136 | 144 | 272 | 383 | 398 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 |
| 234 | 236 | 236 | 236 | 236 | 237 | 266 | 293 | 266 | 267 | |
| 29 | 42 | 70 | 75 | 94 | 104 | 131 | 191 | 205 | 189 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 370 | 550 | 623 | |
| Cash & Bank | 3 | 1 | 2 | 3 | 106 | 224 | 440 | 312 | 269 | 447 |
| 185 | 193 | 214 | 181 | 196 | 290 | 384 | 111 | 123 | 131 | |
| Total Assets | 546 | 560 | 625 | 610 | 761 | 989 | 1,369 | 1,548 | 1,796 | 2,056 |
| Total Debt | 73 | 67 | 78 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
| Net Working Capital | 107 | 121 | 149 | 175 | 254 | 423 | 697 | 675 | 737 | 999 |
| Contingent Liabilities | 9 | 11 | 71 | 140 | 115 | 1 | 1 | 0 | 0 | 0 |
| Book Value per Share | 10.23 | 10.48 | 11.50 | 12.35 | 14.65 | 16.90 | 24.52 | 26.98 | 30.53 | 36.39 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 73 | 67 | 78 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
| Net Working Capital | 107 | 121 | 149 | 175 | 254 | 423 | 697 | 675 | 737 | 999 |
| Contingent Liabilities | 9 | 11 | 71 | 140 | 115 | 1 | 1 | 0 | 0 | 0 |
| Book Value per Share | 10.23 | 10.48 | 11.50 | 12.35 | 14.65 | 16.90 | 24.52 | 26.98 | 30.53 | 36.39 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 41
- 378
- 73
- Trade Payables
- 21
- 33
- Total Liabilities
- 546
- 94
- Capital Work in Progress
- 0
- 234
- 29
- 0
- Cash & Bank
- 3
- 185
- Total Assets
- 546
- Total Debt
- 73
- Net Working Capital
- 107
- Contingent Liabilities
- 9
- Book Value per Share
- 10.23
- Face Value
- 1.00
- Total Debt
- 73
- Net Working Capital
- 107
- Contingent Liabilities
- 9
- Book Value per Share
- 10.23
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 41
- 388
- 66
- Trade Payables
- 34
- 31
- Total Liabilities
- 560
- 88
- Capital Work in Progress
- 0
- 236
- 42
- 0
- Cash & Bank
- 1
- 193
- Total Assets
- 560
- Total Debt
- 67
- Net Working Capital
- 121
- Contingent Liabilities
- 11
- Book Value per Share
- 10.48
- Face Value
- 1.00
- Total Debt
- 67
- Net Working Capital
- 121
- Contingent Liabilities
- 11
- Book Value per Share
- 10.48
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 41
- 430
- 77
- Trade Payables
- 37
- 40
- Total Liabilities
- 625
- 103
- Capital Work in Progress
- 0
- 236
- 70
- 0
- Cash & Bank
- 2
- 214
- Total Assets
- 625
- Total Debt
- 78
- Net Working Capital
- 149
- Contingent Liabilities
- 71
- Book Value per Share
- 11.50
- Face Value
- 1.00
- Total Debt
- 78
- Net Working Capital
- 149
- Contingent Liabilities
- 71
- Book Value per Share
- 11.50
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 41
- 465
- 0
- Trade Payables
- 57
- 48
- Total Liabilities
- 610
- 115
- Capital Work in Progress
- 0
- 236
- 75
- 0
- Cash & Bank
- 3
- 181
- Total Assets
- 610
- Total Debt
- 0
- Net Working Capital
- 175
- Contingent Liabilities
- 140
- Book Value per Share
- 12.35
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 175
- Contingent Liabilities
- 140
- Book Value per Share
- 12.35
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 41
- 559
- 0
- Trade Payables
- 64
- 97
- Total Liabilities
- 761
- 129
- Capital Work in Progress
- 0
- 236
- 94
- 0
- Cash & Bank
- 106
- 196
- Total Assets
- 761
- Total Debt
- 0
- Net Working Capital
- 254
- Contingent Liabilities
- 115
- Book Value per Share
- 14.65
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 254
- Contingent Liabilities
- 115
- Book Value per Share
- 14.65
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 41
- 651
- 5
- Trade Payables
- 74
- 218
- Total Liabilities
- 989
- 136
- Capital Work in Progress
- 0
- 237
- 104
- 0
- Cash & Bank
- 224
- 290
- Total Assets
- 989
- Total Debt
- 5
- Net Working Capital
- 423
- Contingent Liabilities
- 1
- Book Value per Share
- 16.90
- Face Value
- 1.00
- Total Debt
- 5
- Net Working Capital
- 423
- Contingent Liabilities
- 1
- Book Value per Share
- 16.90
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 45
- 1,066
- 0
- Trade Payables
- 112
- 146
- Total Liabilities
- 1,369
- 144
- Capital Work in Progress
- 4
- 266
- 131
- 0
- Cash & Bank
- 440
- 384
- Total Assets
- 1,369
- Total Debt
- 0
- Net Working Capital
- 697
- Contingent Liabilities
- 1
- Book Value per Share
- 24.52
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 697
- Contingent Liabilities
- 1
- Book Value per Share
- 24.52
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 45
- 1,177
- 0
- Trade Payables
- 160
- 166
- Total Liabilities
- 1,548
- 272
- Capital Work in Progress
- 0
- 293
- 191
- 370
- Cash & Bank
- 312
- 111
- Total Assets
- 1,548
- Total Debt
- 0
- Net Working Capital
- 675
- Contingent Liabilities
- 0
- Book Value per Share
- 26.98
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 675
- Contingent Liabilities
- 0
- Book Value per Share
- 26.98
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 45
- 1,338
- 0
- Trade Payables
- 204
- 209
- Total Liabilities
- 1,796
- 383
- Capital Work in Progress
- 0
- 266
- 205
- 550
- Cash & Bank
- 269
- 123
- Total Assets
- 1,796
- Total Debt
- 0
- Net Working Capital
- 737
- Contingent Liabilities
- 0
- Book Value per Share
- 30.53
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 737
- Contingent Liabilities
- 0
- Book Value per Share
- 30.53
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 45
- 1,604
- 0
- Trade Payables
- 181
- 226
- Total Liabilities
- 2,056
- 398
- Capital Work in Progress
- 0
- 267
- 189
- 623
- Cash & Bank
- 447
- 131
- Total Assets
- 2,056
- Total Debt
- 0
- Net Working Capital
- 999
- Contingent Liabilities
- 0
- Book Value per Share
- 36.39
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 999
- Contingent Liabilities
- 0
- Book Value per Share
- 36.39
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -14 | 16 | 20 | 108 | 107 | 56 | 52 | 34 | 31 | 211 | |
| Cash from Investing | -8 | -8 | -20 | -24 | 9 | -128 | -195 | -114 | 17 | -140 |
| Cash from Financing | 21 | -10 | 1 | -82 | -14 | 71 | 210 | -26 | -30 | -39 |
| -1 | -2 | 1 | 2 | 102 | -1 | 67 | -106 | 18 | 32 | |
| Free Cash Flow | -25 | 10 | -3 | 84 | 78 | 32 | 30 | -57 | -110 | 163 |
| OCF / Net Profit | -1.18 | 1.26 | 0.45 | 2.84 | 1.09 | 0.54 | 0.50 | 0.25 | 0.16 | 0.70 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 144 | 201 | 221 | 167 | -27 | 58 |
| OCF / Net Profit | -1.18 | 1.26 | 0.45 | 2.84 | 1.09 | 0.54 | 0.50 | 0.25 | 0.16 | 0.70 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 144 | 201 | 221 | 167 | -27 | 58 |
Mar 2017
- -14
- Cash from Investing
- -8
- Cash from Financing
- 21
- -1
- Free Cash Flow
- -25
- OCF / Net Profit
- -1.18
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.18
- Cumulative 5-Year FCF
- 0
Mar 2018
- 16
- Cash from Investing
- -8
- Cash from Financing
- -10
- -2
- Free Cash Flow
- 10
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 0
Mar 2019
- 20
- Cash from Investing
- -20
- Cash from Financing
- 1
- 1
- Free Cash Flow
- -3
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 0
Mar 2020
- 108
- Cash from Investing
- -24
- Cash from Financing
- -82
- 2
- Free Cash Flow
- 84
- OCF / Net Profit
- 2.84
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.84
- Cumulative 5-Year FCF
- 0
Mar 2021
- 107
- Cash from Investing
- 9
- Cash from Financing
- -14
- 102
- Free Cash Flow
- 78
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 144
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 144
Mar 2022
- 56
- Cash from Investing
- -128
- Cash from Financing
- 71
- -1
- Free Cash Flow
- 32
- OCF / Net Profit
- 0.54
- Cumulative 5-Year FCF
- 201
- OCF / Net Profit
- 0.54
- Cumulative 5-Year FCF
- 201
Mar 2023
- 52
- Cash from Investing
- -195
- Cash from Financing
- 210
- 67
- Free Cash Flow
- 30
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 221
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 221
Mar 2024
- 34
- Cash from Investing
- -114
- Cash from Financing
- -26
- -106
- Free Cash Flow
- -57
- OCF / Net Profit
- 0.25
- Cumulative 5-Year FCF
- 167
- OCF / Net Profit
- 0.25
- Cumulative 5-Year FCF
- 167
Mar 2025
- 31
- Cash from Investing
- 17
- Cash from Financing
- -30
- 18
- Free Cash Flow
- -110
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- -27
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- -27
Mar 2026
- 211
- Cash from Investing
- -140
- Cash from Financing
- -39
- 32
- Free Cash Flow
- 163
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 58
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 58
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.28 | 0.30 | 1.07 | 0.93 | 2.40 | 2.54 | 2.27 | 2.95 | 4.15 | 6.64 |
| Book Value (₹) | 10.23 | 10.48 | 11.50 | 12.35 | 14.65 | 16.90 | 24.52 | 26.98 | 30.53 | 36.39 |
| Dividend per Share (₹) | 0.05 | 0.05 | 0.05 | 0.10 | 0.25 | 0.25 | 0.50 | 0.60 | 0.80 | 0.90 |
| Cash EPS (₹) | 0.65 | 0.60 | 1.28 | 1.21 | 2.77 | 2.97 | 2.64 | 3.59 | 4.80 | 7.39 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 14.57% | 12.41% | 16.80% | 16.53% | 23.98% | 23.44% | 21.91% | 16.36% | 17.66% | 23.50% |
| Net Margin % | 5.35% | 4.22% | 10.28% | 8.75% | 16.28% | 15.63% | 14.79% | 15.63% | 15.97% | 21.84% |
| ROE % | 2.79% | 2.93% | 9.70% | 7.77% | 17.80% | 16.11% | 11.41% | 11.46% | 14.45% | 19.83% |
| ROCE % | 3.44% | 4.92% | 11.99% | 11.39% | 23.46% | 19.91% | 14.27% | 14.81% | 18.76% | 25.88% |
| 2.14% | 2.25% | 7.36% | 6.14% | 14.35% | 11.88% | 8.72% | 9.17% | 11.26% | 15.61% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 244 | 200 | 149 | 143 | 100 | 114 | 145 | 144 | 142 | 155 |
| Inventory Days | 62 | 44 | 48 | 61 | 51 | 54 | 62 | 69 | 61 | 52 |
| Payable Days | 84 | 58 | 55 | 70 | 65 | 67 | 86 | 103 | 104 | 103 |
| 221 | 186 | 143 | 134 | 85 | 101 | 120 | 109 | 100 | 104 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.17x | 0.16x | 0.17x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | 3.66x | 3.17x | 9.54x | 8.23x | 24.26x | 36.44x | 37.54x | 174.98x | 208.21x | 296.06x |
| 1.98x | 2.07x | 2.10x | 3.19x | 2.85x | 3.22x | 3.89x | 3.22x | 2.91x | 3.69x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -39.73% | 36.52% | 43.95% | 2.18% | 38.33% | 9.80% | -0.47% | 30.23% | 37.63% | 14.23% |
| Operating Profit Growth % | -72.07% | 16.34% | 94.84% | 0.56% | 102.15% | 7.66% | -2.30% | 32.56% | 35.58% | 55.94% |
| Net Profit Growth % | -83.85% | 7.64% | 250.98% | -13.10% | 159.56% | 5.70% | -1.08% | 30.03% | 40.76% | 59.71% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.03% | 40.75% | 59.72% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 51.34x | 53.52x | 23.68x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.62x | 7.28x | 4.32x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.40% | 0.36% | 0.57% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 32.45x | 35.81x | 15.63x |
Mar 2017
- EPS (₹)
- 0.28
- Book Value (₹)
- 10.23
- Dividend per Share (₹)
- 0.05
- Cash EPS (₹)
- 0.65
- Operating Margin %
- 14.57%
- Net Margin %
- 5.35%
- ROE %
- 2.79%
- ROCE %
- 3.44%
- 2.14%
- Debtor Days
- 244
- Inventory Days
- 62
- Payable Days
- 84
- 221
- Debt to Equity (x)
- 0.17x
- Interest Coverage (x)
- 3.66x
- 1.98x
- Revenue Growth %
- -39.73%
- Operating Profit Growth %
- -72.07%
- Net Profit Growth %
- -83.85%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 0.30
- Book Value (₹)
- 10.48
- Dividend per Share (₹)
- 0.05
- Cash EPS (₹)
- 0.60
- Operating Margin %
- 12.41%
- Net Margin %
- 4.22%
- ROE %
- 2.93%
- ROCE %
- 4.92%
- 2.25%
- Debtor Days
- 200
- Inventory Days
- 44
- Payable Days
- 58
- 186
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 3.17x
- 2.07x
- Revenue Growth %
- 36.52%
- Operating Profit Growth %
- 16.34%
- Net Profit Growth %
- 7.64%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 1.07
- Book Value (₹)
- 11.50
- Dividend per Share (₹)
- 0.05
- Cash EPS (₹)
- 1.28
- Operating Margin %
- 16.80%
- Net Margin %
- 10.28%
- ROE %
- 9.70%
- ROCE %
- 11.99%
- 7.36%
- Debtor Days
- 149
- Inventory Days
- 48
- Payable Days
- 55
- 143
- Debt to Equity (x)
- 0.17x
- Interest Coverage (x)
- 9.54x
- 2.10x
- Revenue Growth %
- 43.95%
- Operating Profit Growth %
- 94.84%
- Net Profit Growth %
- 250.98%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 0.93
- Book Value (₹)
- 12.35
- Dividend per Share (₹)
- 0.10
- Cash EPS (₹)
- 1.21
- Operating Margin %
- 16.53%
- Net Margin %
- 8.75%
- ROE %
- 7.77%
- ROCE %
- 11.39%
- 6.14%
- Debtor Days
- 143
- Inventory Days
- 61
- Payable Days
- 70
- 134
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 8.23x
- 3.19x
- Revenue Growth %
- 2.18%
- Operating Profit Growth %
- 0.56%
- Net Profit Growth %
- -13.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 2.40
- Book Value (₹)
- 14.65
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 2.77
- Operating Margin %
- 23.98%
- Net Margin %
- 16.28%
- ROE %
- 17.80%
- ROCE %
- 23.46%
- 14.35%
- Debtor Days
- 100
- Inventory Days
- 51
- Payable Days
- 65
- 85
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 24.26x
- 2.85x
- Revenue Growth %
- 38.33%
- Operating Profit Growth %
- 102.15%
- Net Profit Growth %
- 159.56%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 2.54
- Book Value (₹)
- 16.90
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 2.97
- Operating Margin %
- 23.44%
- Net Margin %
- 15.63%
- ROE %
- 16.11%
- ROCE %
- 19.91%
- 11.88%
- Debtor Days
- 114
- Inventory Days
- 54
- Payable Days
- 67
- 101
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 36.44x
- 3.22x
- Revenue Growth %
- 9.80%
- Operating Profit Growth %
- 7.66%
- Net Profit Growth %
- 5.70%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 2.27
- Book Value (₹)
- 24.52
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 2.64
- Operating Margin %
- 21.91%
- Net Margin %
- 14.79%
- ROE %
- 11.41%
- ROCE %
- 14.27%
- 8.72%
- Debtor Days
- 145
- Inventory Days
- 62
- Payable Days
- 86
- 120
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 37.54x
- 3.89x
- Revenue Growth %
- -0.47%
- Operating Profit Growth %
- -2.30%
- Net Profit Growth %
- -1.08%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 2.95
- Book Value (₹)
- 26.98
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 3.59
- Operating Margin %
- 16.36%
- Net Margin %
- 15.63%
- ROE %
- 11.46%
- ROCE %
- 14.81%
- 9.17%
- Debtor Days
- 144
- Inventory Days
- 69
- Payable Days
- 103
- 109
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 174.98x
- 3.22x
- Revenue Growth %
- 30.23%
- Operating Profit Growth %
- 32.56%
- Net Profit Growth %
- 30.03%
- 30.03%
- P/E (x)
- 51.34x
- P/B (x)
- 5.62x
- Dividend Yield %
- 0.40%
- 32.45x
Mar 2025
- EPS (₹)
- 4.15
- Book Value (₹)
- 30.53
- Dividend per Share (₹)
- 0.80
- Cash EPS (₹)
- 4.80
- Operating Margin %
- 17.66%
- Net Margin %
- 15.97%
- ROE %
- 14.45%
- ROCE %
- 18.76%
- 11.26%
- Debtor Days
- 142
- Inventory Days
- 61
- Payable Days
- 104
- 100
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 208.21x
- 2.91x
- Revenue Growth %
- 37.63%
- Operating Profit Growth %
- 35.58%
- Net Profit Growth %
- 40.76%
- 40.75%
- P/E (x)
- 53.52x
- P/B (x)
- 7.28x
- Dividend Yield %
- 0.36%
- 35.81x
Mar 2026
- EPS (₹)
- 6.64
- Book Value (₹)
- 36.39
- Dividend per Share (₹)
- 0.90
- Cash EPS (₹)
- 7.39
- Operating Margin %
- 23.50%
- Net Margin %
- 21.84%
- ROE %
- 19.83%
- ROCE %
- 25.88%
- 15.61%
- Debtor Days
- 155
- Inventory Days
- 52
- Payable Days
- 103
- 104
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 296.06x
- 3.69x
- Revenue Growth %
- 14.23%
- Operating Profit Growth %
- 55.94%
- Net Profit Growth %
- 59.71%
- 59.72%
- P/E (x)
- 23.68x
- P/B (x)
- 4.32x
- Dividend Yield %
- 0.57%
- 15.63x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-20 - Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet Q1 FY 27 Financial Results
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-13 - Marksans Pharma Limited has informed the Exchange about Link of Recording of Conference call Q1 FY 27 Financial Results
Annual Reports
Credit Ratings
- Credit Rating- Revision
2026-06-09 - Marksans Pharma Limited has informed the Exchange that India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable
Concalls
Aug 2026
Jun 2026
May 2026